GNCA 10:09 Genocea price target raised to $12 from $9 at Piper Jaffray Piper Jaffray analyst Edwrd Tenthoff raised Genocea's price target to $12 from $9 following the release of positive data from the on-going Phase IIb bridging study of GEN-003. The analyst has an Overweight rating on shares.